Effect of Imidazole Dipeptide Supplementation on Lipid Metabolism During Aerobic Exercise

Effect of Imidazole Dipeptide Supplementation on Lipid Metabolism During Aerobic Exercise - Effect of Imidazole Dipeptide Supplementation on Lipid Metabolism During Exercise

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000059351

Enrollment

Registered

2025-10-09

Start date

2025-09-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy individuals

Interventions

Participants will consume 2.0 g of imidazole dipeptides or placebo daily for four weeks. Participants will consume 2.0 g of imidazole dipeptides or placebo daily for four weeks.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1. History of cardiovascular, respiratory, or metabolic diseases 2. Allergies to supplement ingredients (e.g., chicken-derived protein, beta-alanine) 3. Current use of substances listed on the 2025 WADA Prohibited List

Design outcomes

Primary

Measure	Time frame
lipid metabolism	—

Secondary

Measure	Time frame
body composition, oxidative stress markers	—

Countries

Japan

Contacts

Public ContactTomoko Kaburagi

Daito Bunka University Faculty of Sports and Health Sciences

t-kabu@ic.daito.ac.jp0493-31-1552

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026